Nuestras Investigaciones - Página 8 de 9 - Fideres

Indexing In Disguise: Closet Trackers Under Fire In Europe

Fideres has found over 16% of European UCITs funds of the sample analyzed show characteristics that may indicate they are

febrero 13, 2017

What Pharmacy Benefit Managers Don’t Want You to Know

Payment flow and pricing structure are highly complex and nontransparent within the US pharmaceutical industry. No single entity having a

febrero 10, 2017

Generic Drug Prices: Why U.S. Costs Keep Rising

Generic drug price increases may be more widespread than the scope of any current lawsuit. Fideres has identified over 90

Twombly Or Not Twombly?

We assess the impact of the Twombly decision on US antitrust class actions. The number of filings has decreased, despite

octubre 7, 2016

Drug Cartels In The USA

Significant price spikes in generic drugs have led to increased scrutiny from lawmakers. Fideres has conducted detailed analysis for the

agosto 28, 2016

Indexers in Hiding: Active Funds That Aren’t So Active

Active share alone can give a biased view of funds’ activeness. Other metrics must be considered alongside active share to

Event Studies: A Legal Tool With Hidden Pitfalls

When relying on event studies in 10b5 securities litigation cases, law firms should consider a number of issues when using

When Corporate Connections Undermine Competition

Top holding ranks in DJUSFN companies are represented by a small number of companies. MHHI and HHI provide a different

The Impact Of Lawsuits On The Stock Market

Fideres analyzed a large sample of securities class actions to determine if the filings have an impact on stock prices.

Why Corporations May Be Paying Too Much To Borrow

Fideres analyzed the pricing of new corporate bond issuances between 2010 and 2015. We found that, on average, bonds are